Introduction:？Worldwide increasing cesarean section rates are
expected to have a parallel increase in the number of cases of Placenta Previa
with all the expected complications, including pathologically adherent
placenta. This morbidly adherent placenta constitutes a serious and possibly a
life threatening complication. An efficient team capable for managing possible
complicated situations will be able to reduce mortality and morbidity.Objectives: The aim of our
study was to evaluate maternal outcome in cases of Placenta Previa with and
without morbidly adherent placenta. Methods: Analysis of all pregnancies complicated by antepartum
hemorrhage during the period from January 2013 to September 2017 at King
Abdul-Aziz University Hospital (KAUH), Jeddah, Kingdom of Saudi Arabia (KSA)
was done. Cases of Placenta Previa with gestational age >28
weeks were included. They were classified into 2 groups; Group (A) included
Placenta Previa cases without morbidly adherent placenta and Group (B) included
cases with morbidly adherent placenta
References
[1]
McShane, P. and Heyl, P. (1985) Maternal and Perinatal Morbidity Resulting from Placenta Previa. Obstetrics & Gynecology, 65, 176-182.
[2]
Chou, M. (2004) Prenatal Diagnosis and Perinatal Management of Placenta Previa Accreta: Past, Present and Future. Taiwanese Journal of Obstetrics and Gynecology, 43, 64-71. https://doi.org/10.1016/S1028-4559(09)60058-9
Frederiksen, F.C., Glassenberg, R. and Stika, C.S. (1999) Placenta Previa: A 22-Year Analysis. American Journal of Obstetrics and Gynecology, 180, 1432-1437.
https://doi.org/10.1016/S0002-9378(99)70031-1
[5]
Takai, I.U., Sayyadi, B.M. and Galadanci, H.S. (2017) A Retrospective Analysis from a Northern Nigerian Teaching Hospital. International Journal of Applied & Basic Medical Research, 7, 112-116. https://doi.org/10.4103/2229-516X.205819
[6]
Faiz, A.S. and Ananth, C.V. (2003) Etiology and Risk Factors for Placenta Previa: An Overview and Meta-Analysis of Observational Studies. The Journal of Maternal-Fetal & Neonatal Medicine, 13, 175-190.
https://doi.org/10.1080/jmf.13.3.175.190
[7]
Abduljabbar, H.S., Bahkali, N.M., Al-Basri, S.F., et al. (2016) Placenta Previa. A 13 Years’ Experience at a Tertiary Care Center in Western Saudi Arabia. Saudi Medical Journal, 37, 762-766. https://doi.org/10.15537/smj.2016.7.13259
[8]
Wu, S., Kocherginsky, M. and Hibbard, J. (2005) Abnormal Placentation: Twenty-Year Analysis. American Journal of Obstetrics and Gynecology, 192, 1458-1461.
https://doi.org/10.1016/j.ajog.2004.12.074
[9]
Kollmann, M., Gaulhofer, J., Lang, U. and Klaritsch, P. (2016) Placenta Praevia: Incidence, Risk Factors and Outcome. The Journal of Maternal-Fetal & Neonatal Medicine, 29, 1395-1398. https://doi.org/10.3109/14767058.2015.1049152
[10]
Committee on Obstetric Practice (2012) Committee Opinion NO. 529: Placenta Accreta. Obstetrics & Gynecology, 120, 207-211.
https://doi.org/10.1097/AOG.0b013e318262e340
[11]
Fitzpatrick, K.E., Sellers, S., Spark, P., Kurinczuk, J.J., Brocklehurst, P. and Knight, M. (2014) The Management and Outcomes of Placenta Accreta, Increta, and Percreta in the UK: A Population-Based Descriptive Study. BJOG, 121, 62-71.
https://doi.org/10.1111/1471-0528.12405
[12]
Silver, R.M., Fox, K.A., Barton, J.R., Abuhamad, A.Z., Simhan, H., Huls, C.K., Belfort, M.A. and Wright, J.D. (2015) Center of Excellence for Placenta Accreta. American Journal of Obstetrics and Gynecology, 212, 561-568.
https://doi.org/10.1016/j.ajog.2014.11.018
[13]
Eller, A.G., Bennett, M.A., Sharshiner, M., Masheter, C., Soisson, A.P., Dodson, M. and Silver, R.M. (2015) Maternal Morbidity in Cases of Placenta Accreta Managed by a Multidisciplinary Care Team Compared with Standard Obstetric Care. Obstetrics & Gynecology, 117, 331-337.
